Intelligent Bio Solutions Inc. (NASDAQ: INBS) is an innovative medical technology company revolutionizing the drug testing industry with its Intelligent Fingerprinting Drug Screening System, a non-invasive solution that uses fingerprint sweat for rapid and reliable drug detection. The company is positioning itself as a leader in the next generation of workplace safety and healthcare solutions.

Recent Highlights: FDA Progress: INBS has achieved a significant milestone by submitting its 510(k) premarket notification to the FDA for its breakthrough technology, targeting U.S. market entry in 2025. Clinical Validation: The company’s clinical studies demonstrate high accuracy rates (94.1%) in detecting drug use through fingerprint sweat, reinforcing the reliability of its solutions. Global Market Expansion: INBS is strengthening its footprint in the UK, securing partnerships with industry leaders like Pyrotek and GPS Marine, and expanding into the retail and logistics sectors to promote workplace safety. Financial Growth: The company achieved a 10% year-over-year revenue increase in Q1 fiscal year 2025, reflecting growing adoption of its technology. Financial & Market Overview: Market Capitalization: $5.70 million Revenue (TTM): $3.19 million Strong Potential: With a focus on innovation and growing partnerships, INBS is poised to capitalize on emerging market opportunities in the U.S. and internationally. Stock Opportunity: Currently trading at $1.63, INBS offers potential for growth as it progresses toward FDA approval and further market penetration. Why Consider INBS? Innovative Edge: The company's non-invasive, fingerprint-based drug screening technology is a game-changer, offering faster and more convenient testing solutions compared to traditional methods. Strategic Vision: With ongoing efforts to expand into the U.S. and new global markets, INBS is on track to transform workplace drug testing standards. Market Momentum: Key partnerships and growing revenue signal strong market interest and adoption of its pioneering technology. Intelligent Bio Solutions stands out as a forward-thinking company with cutting-edge technology and a clear growth trajectory. With FDA approval on the horizon and expanding global partnerships, it offers a compelling opportunity for those looking to invest in the future of medical technology. Expecting at least a 100% upside by next year